CPC Pain & Wellness SPV, LLC Amends XWELL Stake

TL;DR

CPC Pain & Wellness SPV, LLC just updated their XWELL stake filing - watch this space.

AI Summary

On July 22, 2024, CPC Pain & Wellness SPV, LLC, along with Wayne Mack and Richard Waldo, filed an amendment to their Schedule 13D regarding XWELL, Inc. This filing indicates a change in beneficial ownership, with CPC Pain & Wellness SPV, LLC now holding a significant stake in the company. The filing does not specify a dollar amount for their holdings but details changes in their reporting obligations.

Why It Matters

This amendment signals a potential shift in control or influence for XWELL, Inc., as a significant entity has updated its beneficial ownership disclosure.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can indicate activist investor activity or a shift in major shareholders, which may impact stock price and corporate strategy.

Key Players & Entities

• CPC Pain & Wellness SPV, LLC (company) — Filing entity
• XWELL, Inc. (company) — Subject company
• Wayne Mack (person) — Filing entity member
• Richard Waldo (person) — Filing entity member

FAQ

Key Financial Figures

• $0.01 — Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class o
• $1.6403 — hase Purchase of Common Stock 3,000 $1.6403 6/5/2024 Purchase of Common Stock 3
• $1.6574 — 2024 Purchase of Common Stock 3,000 $1.6574 6/6/2024 Purchase of Common Stock 3
• $1.6026 — 2024 Purchase of Common Stock 3,000 $1.6026 6/7/2024 Purchase of Common Stock 4
• $1.6799 — 024 Purchase of Common Stock 41,068 $1.6799 6/10/2024 Purchase of Common Stock
• $1.9073 — 024 Purchase of Common Stock 20,310 $1.9073 6/11/2024 Purchase of Common Stock
• $2.0691 — 024 Purchase of Common Stock 48,921 $2.0691 6/12/2024 Purchase of Common Stock
• $2.3456 — 024 Purchase of Common Stock 46,255 $2.3456 6/13/2024 Purchase of Common Stock
• $2.4972 — 024 Purchase of Common Stock 24,320 $2.4972 6/14/2024 Purchase of Common Stock
• $2.4950 — 2024 Purchase of Common Stock 4,326 $2.4950 6/17/2024 10 of 11

Filing Documents

• cpc240759_13da.htm (SC 13D/A) — 146KB
• cpc240759_ex99-1.htm (EX-99.1) — 13KB
• cpc240759_ex99-2.htm (EX-99.2) — 171KB
• img001_v1.jpg (GRAPHIC) — 91KB
• img002_v1.jpg (GRAPHIC) — 94KB
• img003_v1.jpg (GRAPHIC) — 103KB
• img004_v1.jpg (GRAPHIC) — 77KB
• img005_v1.jpg (GRAPHIC) — 41KB
• img006_v1.jpg (GRAPHIC) — 71KB
• img007_v1.jpg (GRAPHIC) — 126KB
• img008_v1.jpg (GRAPHIC) — 108KB
• 0000897101-24-000311.txt ( ) — 1302KB

From the Filing

SC 13D/A 1 cpc240759_13da.htm AMENDMENT NO. 1 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* XWELL, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 98420U703 (CUSIP Number) Wayne Mack Richard Waldo CPC Pain & Wellness SPV, LLC 301 Edgewater Place, Suite 100 Wakefield, MA 01880 (617) 531-9767 Ben A. Stacke Faegre Drinker Biddle & Reath LLP 2200 Wells Fargo Center 90 S. Seventh Street Minneapolis, Minnesota 55402 (612) 776-7000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) July 19, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box . *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D CUSIP No. 98420U703 1 NAME OF REPORTING PERSON CPC Pain & Wellness SPV, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ( See Instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS ( See Instructions) WC 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 7 SOLE VOTING POWER 0 SHARES BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 394,200 EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 WITH 10 SHARED DISPOSITIVE POWER 394,200 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 394,200 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ( See Instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.42% 1 14 TYPE OF REPORTING PERSON ( See Instructions) OO 1 Based on 4,183,435 shares of Common Stock outstanding as of May 14, 2024 as reported in the Issuer’s quarterly report on Form 10-Q for the quarter ended March 31, 2024. 2 of 11 1 NAME OF REPORTING PERSON ACM-CPC, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ( See Instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS ( See Instructions) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 7 SOLE VOTING POWER 0 SHARES BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 394,200 EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 WITH 10 SHARED DISPOSITIVE POWER 394,200 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 394,200 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ( See Instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.42% 2 14 TYPE OF REPORTING PERSON ( See Instructions) OO 2 Based on 4,183,435 shares of Common Stock outstanding as of May 14, 2024 as reported in the Issuer’s quarterly report on Form 10-Q for the quarter ended March 31, 2024. 3 of 15 1 NAME OF REPORTING PERSON Wayne Mack 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (See Instructions) AF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION United NUMBER OF 7 SOLE VOTING POWER 0 SHARES BENEFICIALLY OWNED BY 8 SHARED VOTING POWER 394,200 EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER 0 WITH 10 SHARED DISPOSITIVE POWER 394,200 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 394,200 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ( See Instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.42% 3 14 TYPE OF REPORTING PERSON ( See Instructions) IN 3 Based on 4,183,435 shares of Common Stock outstanding as of May 14, 2024 as reported in the Issuer’s quarterly report on Form 10-Q for the quarter ended March 31, 2024. 4 of 15 1 NAME OF REPORTING PERSON Richard Waldo 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) (b) 3 SEC USE ONLY 4 SOU

View Full Filing

View this SC 13D/A filing on SEC EDGAR